Back to Search
LAUREL STEINHERZ, MD
MD
Pediatrics Physician
NPI: 1760453237Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
118154(NY)
Research & Publications (12)
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
PMID 19652076·J Clin Oncol·2009
3-trial
Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
PMID 17805046·J Pediatr Hematol Oncol·2007
5-case
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
PMID 16622268·J Clin Oncol·2006
3-trial
Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclines.
PMID 15284267·J Clin Oncol·2004
3-trial
Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.
PMID 14990637·J Clin Oncol·2004
3-trial
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
PMID 12697887·J Clin Oncol·2003
3-trial
Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers.
PMID 12692800·Med Pediatr Oncol·2003
4-observational
Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy.
PMID 12487828·Pediatr Hematol Oncol·2002
8-other
Pythium insidiosum pleuropericarditis complicating pneumonia in a child with leukemia.
PMID 12203186·Clin Infect Dis·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-8103
Quick Facts
- NPI
- 1760453237
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile